The Impact of LRRK2 G2019S on Parkinson's Disease: Clinical Phenotype and Treatment in Tunisian Patients.
Barreh GA, Sghaier I, Abida Y, Gharbi A, Nasri A, Mrabet S, Souissi A, Djebara MB, Trabelsi S, Kacem I, Gargouri-Berrechid A, Gouider R.
Barreh GA, et al. Among authors: abida y.
J Mov Disord. 2024 Jul;17(3):294-303. doi: 10.14802/jmd.23276. Epub 2024 Apr 23.
J Mov Disord. 2024.
PMID: 38649328
Free PMC article.